Drug Trial Radar · NCT00236067
A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
Last checked: Nov 19, 2026Latest source record: May 9, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
440
Actual
Start
Oct 2004
Primary completion
Not stated
Study completion Mar 2006
Sponsor
- Lead sponsor
- CephalonIndustry
- Sponsor type
- Industry
- First posted
- Oct 12, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of an investigational anti-anxiety medication relative to placebo in patients with generalized anxiety disorder (GAD).
Conditions
- Generalized Anxiety Disorder
Interventions
GabitrilDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Reduction of symptomatology associated with Generalized Anxiety Disorder as assessed by the change from baseline to endpoint in the total score of the HAM-A scale.
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
Birmingham Research Group
Birmingham, Alabama
Southwestern Research Institute
Beverly Hills, California
Pharmacology Research Institute
Northridge, California
Pacific Clinical Research
Orange, California
Carman Research
Smyrna, Georgia
Hawaii Clinical Research Center
Honolulu, Hawaii
Hartford Research Group
Florence, Kentucky
Summit Research Network
Okemos, Michigan
CNS Research Institute
Clementon, New Jersey
Social Psychiatry Research Inst.
Brooklyn, New York
Neurobehavioral Research, Inc.
Lawrence, New York
Social Psychiatry Research Inst.
New York, New York
The Medical Research Network
New York, New York
Northcoast Clinical Trials
Beachwood, Ohio
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma
Summit Research Network
Portland, Oregon
University of Pennsylvania
Philadelphia, Pennsylvania
Carolina Clinical Research Services
Columbia, South Carolina
Radiant Research, Salt Lake City
Salt Lake City, Utah
Comprehensive Neuroscience of Northern Virginia
Arlington, Virginia
Summit Research Network
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.